PASITHEA THERAPEUTICS CORP. Defined Contribution Plan, Cost
PASITHEA THERAPEUTICS CORP. (KTTA) reported Defined Contribution Plan, Cost of $26.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. defined contribution plan, cost for the quarter ending 2026-06-30 was $26.00K, a 13.04% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. defined contribution plan, cost for the quarter ending 2026-03-31 was $52.00K, a 20.93% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. defined contribution plan, cost for the quarter ending 2025-06-30 was $23.00K.
- PASITHEA THERAPEUTICS CORP. defined contribution plan, cost for the quarter ending 2025-03-31 was $43.00K.
- PASITHEA THERAPEUTICS CORP. defined contribution plan, cost for fiscal 2025 was $91.00K, a 106.82% increase from fiscal 2024.
- PASITHEA THERAPEUTICS CORP. defined contribution plan, cost for fiscal 2024 was $44.00K.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|
| 2026-06-30 | $26.00K 10-Q · filed 2026-08-14 | $52.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $52.00K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $91.00K 10-K · filed 2026-03-30 | ||
| 2025-06-30 | $23.00K 10-Q · filed 2026-08-14 | $44.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $43.00K 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | $44.00K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |